Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity

Creative Commons License

EROL M. K., COBAN D. T., SÖĞÜTLÜ SARI E., BİLGİN A. B., DOGAN B., OZDEMIR O., ...Daha Fazla

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, cilt.78, sa.6, ss.340-343, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5935/0004-2749.20150090
  • Dergi Adı: ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.340-343
  • Anahtar Kelimeler: Retinopathy of prematurity, Vascular endothelial growth factor A, Antibodies, monoclonal, Angiogenesis inhibitors, Intravitreal injections, ENDOTHELIAL GROWTH-FACTOR, ZONE-I, THERAPY, INJECTION, LASER, AVASTIN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: To compare the efficacy of intravitreal ranibizumab and bevacizumab treatment for type 1 retinopathy of prematurity (ROP).